[1] Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people[J]. Lancet, 2013, 381:752-762. [2] Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG. The cardiovascular health study:design and rationale[J]. Ann Epidemiol, 1991, 1:263-276. [3] Chen X, Mao G, Leng SX. Frailty syndrome:an overview[J]. Clin Interv Aging, 2014, 9:433-441. [4] Fulop T, Witkowski JM, Olivieri F, Larbi A. The integration of inflammaging in age-related diseases[J]. Semin Immunol, 2018, 40:17-35. [5] Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α[J]. Eur J Med Res, 2017, 22:25. [6] Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength[J]. Am J Med, 2006, 119:E9-17. [7] Cesari M, Kritchevsky SB, Nicklas B, Kanaya AM, Patrignani P, Tacconelli S, Tranah GJ, Tognoni G, Harris TB, Incalzi RA, Newman AB, Pahor M; Health ABC Study. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons:results from the health aging and body composition study[J]. J Gerontol A Biol Sci Med Sci, 2012, 67:671-676. [8] Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylhä M. Inflammatory markers and physical performance among nonagenarians[J]. J Gerontol A Biol Sci Med Sci, 2010, 65:658-663. [9] Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, Visser M; Health ABC Study. Higher inflammatory marker levels in older persons:associations with 5-year change in muscle mass and muscle strength[J]. J Gerontol A Biol Sci Med Sci, 2009, 64:1183-1189. [10] Zoico E, Corzato F, Bambace C, Rossi AP, Micciolo R, Cinti S, Harris TB, Zamboni M. Myosteatosis and myofibrosis:relationship with aging, inflammation and insulin resistance[J]. Arch Gerontol Geriatr, 2013, 57:411-416. [11] Roubenoff R, Hughes VA. Sarcopenia:current concepts[J]. J Gerontol A Biol Sci Med Sci, 2000, 55:M716-724. [12] Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, Parker C, Dunn M, Catt M, Jagger C, von Zglinicki T, Kirkwood TB. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old:cross-sectional findings from the Newcastle 85+ Study[J]. Mech Ageing Dev, 2012, 133:456-466. [13] Fernández-Garrido J, Navarro-Martínez R, Buigues-González C, Martínez-Martínez M, Ruiz-Ros V, Cauli O. The value of neutrophil and lymphocyte count in frail older women[J]. Exp Gerontol, 2014, 54:35-41. [14] Hazeldine J, Harris P, Chapple IL, Grant M, Greenwood H, Livesey A, Sapey E, Lord JM. Impaired neutrophil extracellular trap formation:a novel defect in the innate immune system of aged individuals[J]. Aging Cell, 2014, 13:690-698. [15] Stefanaki C, Peppa M, Boschiero D, Chrousos GP. Healthy overweight/obese youth:early osteosarcopenic obesity features[J]. Eur J Clin Invest, 2016, 46:767-778. [16] Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, Sergi G, Isik AT, Manzato E, Maggi S, Maggio M, Prina AM, Cosco TD, Wu YT, Veronese N. Inflammation and frailty in the elderly:a systematic review and meta-analysis[J]. Ageing Res Rev, 2016, 31:1-8. [17] Wannamethee SG, Atkins JL. Muscle loss and obesity:the health implications of sarcopenia and sarcopenic obesity[J]. Proc Nutr Soc, 2015, 74:405-412. [18] Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G, Ormsbee MJ. Interrelationship among muscle, fat, and bone:connecting the dots on cellular, hormonal, and whole body levels[J]. Ageing Res Rev, 2014, 15:51-60. [19] Ormsbee MJ, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A, Panton L. Osteosarcopenic obesity:the role of bone, muscle, and fat on health[J]. J Cachexia Sarcopenia Muscle, 2014, 5:183-192. [20] Riedl A, Vogt S, Holle R, de Las Heras Gala T, Laxy M, Peters A, Thorand B. Comparison of different measures of obesity in their association with health-related quality of life in older adults-eresults from the KORA-Age Study[J]. Public Health Nutr, 2016, 19:3276-3286. [21] Woo T, Yu S, Visvanathan R. Systematic literature review on the relationship between biomarkers of sarcopenia and quality of life in older people[J]. J Frailty Aging, 2016, 5:88-99. [22] Franceschi C, Campisi J. Chronic inflammation (inflammaging) and itspotential contribution to age-associated diseases[J]. J Gerontol A Biol Sci Med Sci, 2014, 69:S4-9. [23] Ferrucci L, Fabbri E. Inflammageing:chronic inflammation in ageing, cardiovascular disease, and frailty[J]. Nat Rev Cardiol, 2018, 15:505-522. [24] Zhang X, Meng X, Chen Y, Leng SX, Zhang H. The biology of aging and cancer:frailty, inflammation, and immunity[J]. Cancer J, 2017, 23:201-205. [25] Van Epps P, Oswald D, Higgins PA, Hornick TR, Aung H, Banks RE, Wilson BM, Burant C, Graventstein S, Canaday DH. Frailty has a stronger association with inflammation than age in older veterans[J]. Immun Ageing, 2016, 13:27. [26] Boulos C, Salameh P, Barberger-Gateau P. Malnutrition and frailty in community dwelling older adults living in arural setting[J]. Clin Nutr, 2016, 35:138-143. [27] Samson LD, Boots AM, Verschuren WM, Picavet HS, Engelfriet P, Buisman AM. Frailty is associated with elevated CRP trajectories and higher numbers of neutrophils and monocytes[J]. Exp Gerontol, 2019, 125:110674. [28] Nevalainen T, Autio A, Kummola L, Salomaa T, Junttila I, Jylha M, Hurme M. CD27- IgD- B cell memory subset associates with inflammation and frailty in elderly individuals but only in males[J]. Immun Ageing, 2019, 16:19. [29] Qu T, Yang H, Walston JD, Fedarko NS, Leng SX. Upregulated monocytic expression of CXC chemokine ligand 10(CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty[J]. Cytokine, 2009, 46:319-324. [30] Liberman K, Njemini R, Luiking Y, Forti LN, Verlaan S, Bauer JM, Memelink R, Brandt K, Donini LM, Maggio M, Mets T, Wijers SL, Sieber C, Cederholm T, Bautmans I. Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults:the PROVIDE Study[J]. Aging Clin Exp Res, 2019, 31:845-854. [31] De Vita F, Lauretani F, Bauer J, Bautmans I, Shardell M, Cherubini A, Bondi G, Zuliani G, Bandinelli S, Pedrazzoni M, Dall'Aglio E, Ceda GP, Maggio M. Relationship between vitamin D and inflammatory markers in older individuals[J]. Age (Dordr), 2014, 36:9694. [32] Vanherwegen AS, Gysemans C, Mathieu C. Vitamin D endocrinology on the cross-road between immunity and metabolism[J]. Mol Cell Endocrinol, 2017, 453:52-67. [33] Xia Z, Cholewa J, Zhao Y, Shang HY, Yang YQ, Araújo Pessôa K, Su QS, Lima-Soares F, Zanchi NE. Targeting inflammation and downstream protein metabolism in sarcopenia:a brief up-dated description of concurrent exercise and leucine-based multimodal intervention[J]. Front Physiol, 2017, 8:434. [34] Jung S, Kim MK, Choi BY. The relationship between zinc status and inflammatory marker levels in rural Korean adults aged 40 and older[J]. PLoS One, 2015, 10:E0130016. [35] Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control:a systematic review and meta-analysis[J]. Ageing Res Rev, 2017, 40:31-44. [36] Ridker PM, Danielsen E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Mac Fadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein[J]. N Engl J Med, 2008, 359:2195-2207. [37] Band MM, Sumukadas D, Struthers AD, Avenell A, Donnan PT, Kemp PR, Smith KT, Hume CL, Hapca A, Witham MD. Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial):study protocol for a randomised controlled trial[J]. Trials, 2018, 19:6. [38] Keller K, Kane A, Heinze-Milne S, Grandy SA, Howlett SE. Chronic treatment with the ACE inhibitor enalapril attenuates the development of frailty and differentially modifies pro- and anti-inflammatory cytokines in aging male and female C57BL/6 mice[J]. J Gerontol A Biol Sci Med Sci, 2019, 74:1149-1157. [39] Pedersen BK. Anti-inflammatory effects of exercise:role in diabetes and cardiovascular disease[J]. Eur J Clin Invest, 2017, 47:600-611. [40] Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, Pahor M, Taaffe DR, Brach J, Rubin S, Harris TB. Physical activity, exercise, and inflammatory markers in older adults:findings from the Health, Aging and Body Composition Study[J]. J Am Geriatr Soc, 2004, 52:1098-1104. [41] Beavers KM, Hsu FC, Isom S, Kritchevsky SB, Church T, Goodpaster B, Pahor M, Nicklas BJ. Long-term physical activity and inflammatory biomarkers in older adults[J]. Med Sci Sports Exerc, 2010, 42:2189-2196. |